Surface Plasmon Resonance Market, by Product Type (ImagingSystem, Sensor System, Reagents) and Application (Drug Discovery (Drug Formulation, Controlled Drug Release, Drug-cell Interactions, (Material Science(New Material and Coatings, Process Optimization), Biosensors, (Food Safety, Environmental Safety, Cancer, DNA, Nanosafety) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : May 2023

Code : CMI3283

Pages :170

Formats :

Excel and PDF

Industry : Pharmaceutical

Market Challenges And Opportunities

Global Surface Plasmon Resonance Market – Driver

Increasing application of Surface Plasmon Resonance in the field of drug discovery

Increasing application of surface plasmon resonance by key market players is expected to drive the surface plasmon resonance market over the forecast period. Using surface plasmon resonance has a high impact on drug discovery and development. Small molecule drug discovery and development is known to be an expensive and time-consuming endeavour, which is not always successful. Surface plasmon resonance is frequently used for target identification and ligand fishing in proteomics, target assay validation for High Throughput Screening (HTS), rapid affinity ranking and detailed kinetics of interaction for small molecules binding to target proteins.

It is also used in lead optimization, early ADME, stratification of patient response to therapeutics in clinical trials, immunogenicity assessment including anti-drug antibody (ADA) responses of biotherapeutics, vaccine development including immune response analysis, and even in manufacturing such as process and batch QC of therapeutic antibodies and proteins.

Global Surface Plasmon Resonance Market: Restraint

High cost of the surface plasmon resonance products

The global surface plasmon resonance market can be hindered by inadequate data high cost of the surface plasmon resonance products. For instance, cost of imaging systems offered by Biacore company is the provider of technologies and services that advance and accelerate the development, manufacture, and delivery of therapeutics. (acquired by GE Healthcare) range between US$ 200,000 and US$ 300,000. Moreover, reagents supporting such systems are also costly and increase the overall cost per interaction.